New weight loss pill set to rival 'fat jab' shows promising results in early trials
A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results in initial trials, according to a new study.
In one of the tests, 125 adults were assigned weekly injections of a drug called 'AMYCRETIN', and early results showed that those receiving the 60 milligram dose lost nearly a quarter of their body weight over 36 weeks.
'Amycretin' is a 'unimolecular long-acting GLP-1 and amylin receptor agonist' under development by Novo Nordisk, to provide a treatment for adults with obesity and as a treatment for adults with type 2 diabetes. Pic: Shutterstock
If the initial results turn out to be effective in the long run, this may make 'Amycretin' a more effective treatment for obesity than other weight loss drugs like Weygovy and Ozempic.
Another trial enrolled 144 adults to test the 'pill version' of 'Amycretin'. Those who took the 100 milligram daily tablet lost an average of 13.1 percent of their weight over 12 weeks.
Novo-Nordisk, who are heading up the research into this new medication says initial trials suggest Amycretin could be on the market by next year. Pic: Getty Images
The strongest prescription weight loss medication currently approved by the FDA is Semaglutide, marketed under brand names like Wegovy and Ozempic (for diabetes, also used off-label for weight loss).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Extra.ie
5 hours ago
- Extra.ie
New weight loss pill set to rival 'fat jab' shows promising results in early trials
A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results in initial trials, according to a new study. In one of the tests, 125 adults were assigned weekly injections of a drug called 'AMYCRETIN', and early results showed that those receiving the 60 milligram dose lost nearly a quarter of their body weight over 36 weeks. 'Amycretin' is a 'unimolecular long-acting GLP-1 and amylin receptor agonist' under development by Novo Nordisk, to provide a treatment for adults with obesity and as a treatment for adults with type 2 diabetes. Pic: Shutterstock If the initial results turn out to be effective in the long run, this may make 'Amycretin' a more effective treatment for obesity than other weight loss drugs like Weygovy and Ozempic. Another trial enrolled 144 adults to test the 'pill version' of 'Amycretin'. Those who took the 100 milligram daily tablet lost an average of 13.1 percent of their weight over 12 weeks. Novo-Nordisk, who are heading up the research into this new medication says initial trials suggest Amycretin could be on the market by next year. Pic: Getty Images The strongest prescription weight loss medication currently approved by the FDA is Semaglutide, marketed under brand names like Wegovy and Ozempic (for diabetes, also used off-label for weight loss).
The Irish Sun
9 hours ago
- The Irish Sun
New ‘Ozempic pill' is better than ‘skinny jabs' and helps you lose weight even faster, study suggests
A NEW 'Ozempic pill' leads to faster weight loss than the popular 'skinny jabs', studies have suggested. The new weight loss medication, which can also be offered by injection, can help patients lose a significant amount of weight. Advertisement 1 The new weight loss pill has seen promising results in early trials Credit: Getty An early study found that patients who received amycretin as a weekly jab lost 24% of their body weight after 36 weeks of treatment. But initial trials assessing a tablet form of the jab saw promising results with patients losing an average 13% of bodyweight in just three months. This suggests the drug leads to greater weight loss than Wegovy, the 'sister jab' of Ozempic. Such treatments have been called transformative by NHS leaders. Advertisement Read more Health news It's estimated that around 1.5 million Brits currently receive weight loss jabs through specialist weight loss services or private prescriptions. But weight pills offer a new hope to millions looking to lose weight as the injections put additional pressure on an overstretched NHS. However, further clinical trials are needed before the treatment can be made available in the UK. This could take several years and there's no guarantee that regulators will approve the use of the drug. Advertisement Most read in Health Amycretin, made by Novo Nordisk, contains semaglutide, the same active ingredient as Ozempic and Wegovy and helps control blood sugar and appetite. It targets specific receptors in the body - the GLP-1 and amylin receptors - helping you feel full and stops overeating. An early trial published in The Lancet found that 125 adults taking weekly injections containing higher doses of the drug lost nearly a quarter of their body weight after 36 weeks. It also showed signs of improving blood sugar levels. Advertisement However, there were some mild to moderate side effects including nausea and vomiting but these were resolved by the end of the treatment. Experts said that the medicine appeared "safe and tolerable" but further studies were needed to fully assess the drug. But a second trial, also published in The Lancet, assessed the drug in tablet form in 144 people. Those taking the highest dose of 100mg lost 13% of their body weight over four months. Advertisement Weight Loss Jabs - Pros vs Cons The authors wrote: "Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people who were overweight or obese. "Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen." As with the first trial, there were also some mild to moderate side effects including loss of appetite and similar gastrointestinal issues. It comes as a separate study examined the effects of the weight-loss jab, Wegovy, at higher doses. Advertisement The researchers found that giving patients 7.2mg of Wegovy once a week led to an average weight loss of 21%, with a third of participants losing 25% of their body weight over 72 weeks. The studies were also presented to the American Diabetes Association's Scientific Sessions in
Extra.ie
11 hours ago
- Extra.ie
Urgent health warning to Irish holidaymakers this summer
The Health Service Executive (HSE) has issued a new travel health warning for Irish citizens planning trips abroad this summer. The advisory comes in response to a recent surge in reported cases of measles in several popular holiday destinations. These locations include a number of European cities as well as USA, Canada, Vietnam, Cambodia and the Philippines. The Health Service Executive (HSE) has issued a new travel health warning for Irish citizens planning trips abroad this summer. Pic: Getty Images The HSE is urging travellers to take extra precautions, including checking vaccination requirements and staying informed about local health risks before and during their travels. In a statement released this week, the Health Service wrote: 'The HSE is concerned that measles outbreaks may occur in Ireland this summer as families with unvaccinated children and adults travel to countries where measles cases have been reported. 'The best way to protect you and your family against measles is to ensure all family members are up to date with the recommended doses of MMR vaccine before travelling abroad.' The advisory comes in response to a recent surge in reported cases of measles in several popular holiday destinations. Pic: Shutterstock The MMR vaccine is available free of charge at your GP for individuals born on or after January 1st 1978 who are not 'age-appropriately vaccinated.' Also, infants aged 6 months to under 12 months are eligible to receive an MMR vaccine, free of charge with their GP, prior to travel abroad. It is recommended to receive the vaccine at least 14 days prior to travel. These locations include a number of European cities as well as USA, Canada, Vietnam, Cambodia and the Philippines. Pic: Shutterstock Sharing further concerns, they added: 'Measles is one of the most highly infectious diseases and spreads rapidly among individuals who are unvaccinated. Measles cases continue to be reported in most European countries, with large outbreaks reported in some countries in 2025. In the latest measles report from ECDC the highest number of cases were reported in: France Spain Romania Netherlands Belgium 'Large numbers of cases have also been reported in the USA, Canada and some countries in Asia – including Vietnam, Cambodia and the Philippines.' More information is available here.
